Primary Site >> Pancreatic Cancer
Gene >> ERBB4
|
|
|
|
|
|
|
|
|
|---|---|---|---|---|---|---|---|---|
|
Ref: Mechanisms of resistance to Erbitux (anti-epidermal growth factor receptor) combination therapy in pancreatic adenocarcinoma cells. PMID: 15585383 Ref: [(11)C]N-(3-Ethynylphenyl)-6,7-bis(2-methoxyethoxy)-4-quinazolinamine PMID: 20641864 |
Ref: Tyrosine kinase inhibitors. 19. 6-Alkynamides of 4-anilinoquinazolines and 4-anilinopyrido[3,4-d]pyrimidines as irreversible inhibitors of the erbB family of tyrosine kinase receptors. PMID: 16480284 |
Ref: Epidermal growth factor receptor regulates pancreatic fibrosis. PMID: 19608732 |
Ref: Radiosensitization of epidermal growth factor receptor/HER2-positive pancreatic cancer is mediated by inhibition of Akt independent of ras mutational status. PMID: 20103665 |
Ref: Ligand stimulation of ErbB4 and a constitutively-active ErbB4 mutant result in different biological responses in human pancreatic tumor cell lines. PMID: 21110957 |
Ref: Targeting EGFR in pancreatic cancer treatment. PMID: 22458527 |
Ref: Multiple Functional Motifs Are Required for the Tumor Suppressor Activity of a Constitutively-Active ErbB4 Mutant. PMID: 24791013 |
Ref: The ErbB/HER family of protein-tyrosine kinases and cancer. PMID: 24269963 Ref: A comprehensive review of the preclinical efficacy profile of the ErbB family blocker afatinib in cancer. PMID: 24643470 |
Ref: The hepatitis B virus X protein promotes pancreatic cancer through modulation of the PI3K/AKT signaling pathway. PMID: 27339327 Ref: The prognostic significance of human epidermal growth factor receptor family protein expression in operable pancreatic cancer : HER1-4 protein expression and prognosis in pancreatic cancer. PMID: 27871278 |